Nicholas Laccona - 30 Sep 2021 Form 3 Insider Report for Bellerophon Therapeutics, Inc. (BLPH)

Role
Controller, (PFO & PAO)
Signature
/s/ Nicholas Laccona
Issuer symbol
BLPH
Transactions as of
30 Sep 2021
Transactions value $
$0
Form type
3
Filing time
08 Oct 2021, 17:26:36 UTC
Next filing
28 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BLPH Stock Options (right to buy) 30 Sep 2021 Common Stock 1,500 $10.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests as to 25% of the underlying shares on August 17, 2021 and the remaining options vest quarterly over a period of 3 years thereafter.